Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |